Stoke Therapeutics Inc.

NASDAQ: STOK · Real-Time Price · USD
18.16
0.99 (5.77%)
At close: Aug 15, 2025, 3:59 PM
18.32
0.85%
After-hours: Aug 15, 2025, 07:44 PM EDT

Stoke Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-23.48M 112.88M -10.48M -26.43M -25.7M -26.37M -26.96M -24.54M -30.65M -22.55M -25.66M -26.11M -24.65M -24.65M -24.45M -22.6M -21.97M -16.79M
Depreciation & Amortization
446K 477K 526K 540K 548K 563K 624K 637K 611K 597K 609K 388K 302K 247K 235K 254K 249K 236K
Stock-Based Compensation
7.6M 6.75M 7.14M 7.49M 7.53M 5.51M 6.06M 6.65M 6.76M 5.89M 5.79M 5.93M 6.16M 4.97M 4.69M 4.61M 4.45M 2.7M
Other Working Capital
-6.87M 6.87M -22.36M -2.49M -3.61M -2.77M 274K -2.37M 5.5M -6.23M -2.88M -1.35M -2.83M 54.75M -71K 2.68M 1.12M -1.08M
Other Non-Cash Items
1.63M 105K -200K 24K 173K 426K 502K 342K 556K 582K 392K 434K 340K 612K 386K 322K 277K 271K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 57K 49K 37K 29K
Change in Working Capital
-11.61M 11.61M -20.18M -3.24M -30K -4.69M -875K -351K 1.07M -5.88M -3.51M -2.69M -2.08M 51.31M 2.83M 2.68M 1.12M -6.58M
Operating Cash Flow
-25.42M 131.83M -23.19M -21.61M -17.48M -24.57M -20.65M -17.26M -21.8M -21.36M -22.37M -22.06M -19.93M 32.49M -16.26M -14.68M -15.83M -20.14M
Capital Expenditures
-154K -152K -42K -103K -46K -12K -229K -383K -839K -165K -409K -2.03M -682K -841K -203K -273K -520K -204K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -45.34M -69.29M 45.34M n/a 70.44M n/a n/a n/a
Purchase of Investments
-181.55M -19.02M -29.14M -49.9M -88.23M n/a n/a n/a n/a n/a 4.87M -9.71M -52.54M -143.94M -82.23M -4.99M -82.23M n/a
Sales Maturities Of Investments
33.23M 32.8M 30M 20M n/a 10M 15M 15M 24.31M 53.25M 18.03M 79M 53.37M 9M 12M n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a 24.31M 53.25M 45.34M 69.29M -45.34M -134.94M 11.8M -4.99M -82.23M n/a
Investing Cash Flow
-148.48M 13.63M 819K -30M -88.28M 9.99M 14.77M 14.62M 23.47M 53.09M 22.49M 67.26M 146K -135.78M 11.8M -5.26M -82.75M -204K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
554K n/a 567K 503K 766K 418K 5K n/a 48K 311K 43K 434K 326K 262K 171K 408K 159K 546K
Financial Cash Flow
554K 1.37M 568K 8.16M 120.65M 1.72M 7.34M 562K 48K 45.05M 43K 434K 3.42M 42.51M 171K 408K 159K 546K
Net Cash Flow
-173.34M 146.83M -21.81M -43.46M 14.89M -12.86M 1.47M -2.08M 1.72M 76.78M 160K 45.64M -16.36M -60.78M -4.29M -19.54M -98.43M -19.79M
Free Cash Flow
-25.58M 131.68M -23.23M -21.72M -17.52M -24.58M -20.88M -17.64M -22.64M -21.52M -22.78M -24.09M -20.61M 31.65M -16.46M -14.96M -16.35M -20.34M